Clinical Trials

Ananda Pharma Advances MRX1 CBD Solution to Phase II Trials
Research & Development Ananda Pharma Advances MRX1 CBD Solution to Phase II Trials

The landscape of botanical medicine underwent a massive transformation as pharmaceutical-grade cannabinoid research transitioned from niche experimentation to a cornerstone of modern therapeutic development. Ananda Pharma has positioned itself at the forefront of this evolution by announcing the

Targeting IL1RAP Overcomes Pancreatic Cancer Resistance
Research & Development Targeting IL1RAP Overcomes Pancreatic Cancer Resistance

Pancreatic cancer has remained an almost invincible adversary in the medical world, frequently defying the very treatments that have successfully tamed other aggressive forms of the disease. While oncology has celebrated remarkable progress in targeted therapies, pancreatic ductal adenocarcinoma

Can Stockholm3 Outperform the Traditional PSA Test?
Research & Development Can Stockholm3 Outperform the Traditional PSA Test?

The landscape of oncology is often defined by the tension between early intervention and the risk of over-treatment, a dilemma nowhere more apparent than in prostate cancer screening. For decades, the medical community has relied on the Prostate-Specific Antigen (PSA) test, a tool that, while

Trend Analysis: HIV Positive Lung Transplants
Tech & Innovation Trend Analysis: HIV Positive Lung Transplants

The realization of a historic medical breakthrough at NYU Langone Health has shattered a long-standing surgical ceiling, proving that HIV-positive organs can offer a second chance at life for recipients facing terminal respiratory failure. For the 1.2 million people living with HIV in the United

UCLA Advances CAR-T Therapy for Pediatric Bone Cancer
Tech & Innovation UCLA Advances CAR-T Therapy for Pediatric Bone Cancer

While significant progress has been made in the treatment of many childhood illnesses, pediatric bone cancer continues to present a formidable obstacle for oncologists and researchers alike. Dr. Theodore Scott Nowicki, a prominent researcher at UCLA, was recently recognized for his innovative

Can Hookworms Be Reprogrammed as Living Drug Factories?
Research & Development Can Hookworms Be Reprogrammed as Living Drug Factories?

The transformation of human hookworms from harmful intestinal parasites into sophisticated, living drug factories represents one of the most radical shifts in modern bioengineering and therapeutic delivery. While these organisms have historically been associated with disease and malnutrition in

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later